Nebraska doctors ID experimental Ebola drug used


Save Story

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

OMAHA, Neb. (AP) — The Nebraska doctors treating an American aid worker battling Ebola have identified the experimental drug they used.

Dr. Phil Smith of the Nebraska Medical Center says Dr. Rick Sacra received a Tekmira Pharmaceuticals drug called TKM-Ebola for a week after he arrived in Omaha on Sept. 5.

Sacra continues to improve, and doctors said Monday that he may be well enough to leave the hospital's isolation unit soon.

But Dr. Angela Hewlett said it's not clear what role the experimental drug played in Sacra's recovery because he also received a blood transfusion from an Ebola survivor and other treatments.

The 51-year-old Rick Sacra from Worcester, Massachusetts, contracted Ebola while working at a hospital in Liberia.

The Ebola virus is being blamed for more than 2,800 deaths in West Africa.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent U.S. stories

Related topics

U.S.
The Associated Press

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast